Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging significant accounting irregularities and misleading disclosures that resulted in inflated profits and concealed losses during the period from May 16, 2024, to August 5, 2025 [1][3]. Summary by Sections Lawsuit Details - The lawsuit is initiated by Berger Montague PC on behalf of investors who purchased Marex shares during the specified class period [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff representatives [2]. Allegations - A report by NINGI Research on August 5, 2025, claims that Marex engaged in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions [3]. - The report highlights discrepancies in intercompany receivables and loans, including a fabricated $17 million receivable and a subsidiary's profits inflated by 150% before liquidation [4]. Financial Impact - Following the report's release, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31, indicating significant investor losses [5].

Company Overview - Marex Group plc is a diversified global financial services platform providing essential liquidity, market access, and infrastructure services across energy, commodities, and financial markets [2] - The company offers four core services: Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions [2] - Marex has a leading franchise in major metals, energy, and agricultural products, with access to 60 exchanges globally [2] - The company serves a broad range of clients, including large commodity producers, consumers, traders, banks, hedge funds, and asset managers [2] - Marex operates more than 40 offices worldwide and employs over 2,400 staff across Europe, Asia, and the Americas [2] Recent Developments - CEO Ian Lowitt purchased 32,465 ordinary shares in Marex on October 10, increasing his total holding to 2,615,016 ordinary shares [1]

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc for alleged violations of federal securities laws, impacting investors who acquired Marex securities between May 16, 2024, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Marex made materially false and misleading statements and failed to disclose conflicts of interest related to over-the-counter financial products sold to itself [3]. - It is alleged that Marex's financial statements contained significant inconsistencies between subsidiaries and related parties, leading to unreliable financial reporting [3]. - The lawsuit asserts that the public statements made by Marex regarding its business and financial condition were false and misleading throughout the class period, resulting in investor damages when the truth emerged [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Marex have until December 8, 2025, to request appointment as lead plaintiff in the class action [4]. - A copy of the Complaint can be reviewed on the law firm's website, and interested parties can contact the firm for more information [4]. Group 3: Legal Representation - The law firm Bronstein, Gewirtz & Grossman operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if the case is successful [5]. - The firm has a strong track record, having recovered hundreds of millions of dollars for investors in securities fraud class actions [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [4][6]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits, citing a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [8]. Group 2: Legal Proceedings and Investor Actions - Investors who suffered losses in Marex between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action is designated to the investor with the largest financial interest who is typical of class members, with the option for any member to move the court to serve as lead plaintiff [9]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Marex's conduct [10].

LOS ANGELES--(BUSINESS WIRE)--Marex Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MRX. ...

LOS ANGELES--(BUSINESS WIRE)---- $MRX--MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm. ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who sold short Marex Group PLC securities, alleging that the company misled investors regarding its financial performance and revenue projections [1][2]. Group 1: Allegations Against Marex Group PLC - The lawsuit claims that Marex Group PLC improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2]. - As a result of these alleged misrepresentations, class members have reportedly suffered significant losses and damages [2]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit their papers to the court by December 8, 2025, to represent the class in the litigation [3]. - Investors do not need to participate actively in the case to be eligible for any potential recovery, and they can remain absent class members if they choose [3]. Group 3: Robbins LLP Overview - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [4].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc for alleged securities fraud, with claims of significant accounting irregularities and misleading disclosures impacting investors [1][5]. Group 1: Allegations and Findings - A report by NINGI Research on August 5, 2025, accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to conceal losses and inflate profits [3]. - The report highlighted discrepancies, including a $17 million receivable created without basis, a subsidiary's profit inflated by 150%, and an asset sold for $2.5 million that was previously valued at $14.9 million [3]. - It was alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund, misclassifying structured note issuance as income to inflate cash flow [3]. Group 2: Market Reaction - Following the publication of the report, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31 per share on August 5, 2025, with unusually high trading volume [4]. Group 3: Lawsuit Details - The class action complaint claims that Marex's management made materially false statements and failed to disclose adverse facts about the company's financial health, including inconsistencies in financial statements and reliance on misleading positive statements [5]. - Specific allegations include the sale of over-the-counter financial instruments to itself and the unreliability of Marex's financial statements due to discrepancies in intercompany transactions [5].

NEW YORK--(BUSINESS WIRE)---- $MRX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex†or the "Company†) (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm ha ...

Core Points - Holzer & Holzer, LLC has filed a shareholder class action lawsuit against Marex, Inc. alleging undisclosed financial practices [1] - The lawsuit claims Marex sold over-the-counter financial instruments to itself and had inconsistencies in financial statements [1] - It is asserted that Marex's financial statements could not be relied upon, leading to misleading positive statements about the company's operations [1] Legal Context - Shareholders who purchased Marex shares between May 16, 2024, and August 5, 2025, and suffered losses are encouraged to seek legal advice [2] - The deadline to apply for lead plaintiff status in the lawsuit is December 8, 2025 [3] - Holzer & Holzer, LLC is recognized for its representation of shareholders and has recovered significant amounts for victims of corporate misconduct [3]